FibroGen

+$0.14 (+1.64%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.

About FGEN

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.

CEO
Enrique A. Conterno
Employees
566
Headquarters
San Francisco, California
Founded
1993

FGEN Key Statistics

Market cap
807.96M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.29M
High today
$8.71
Low today
$8.25
Open price
$8.47
Volume
2.17M
52 Week high
$30.12
52 Week low
$7.81

FGEN News

Simply Wall StMay 20

Investors three-year losses grow to 76% as the stock sheds US$91m this past week

As every investor would know, not every swing hits the sweet spot. But really big losses can really drag down an overall portfolio. So spare a thought for the l

FGEN Earnings

-$1.45
-$0.79
-$0.12
$0.54
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure